AI Briefing: Hillary Clinton and Eric Schmidt Call for Section 230 Reformby Lilu Anderson 06.04.2024Tech companies are facing challenges with AI-generated content. Clinton and Makanju highlight concerns and the need for regulation. TikTok is ...
Altcoin Boom: Analyst Forecasts $1M by 2025by John Darbie 06.04.2024Cyril-DeFi's projections suggest potential 50x-100x returns in the upcoming alt season, with assets possibly soaring to $500k-$1M by 2025. However, ...
Shiba Inu Price Surge Predicted: Crypto Analysts Bullishby John Darbie 06.04.2024Shiba Inu (SHIB) has dipped below $0.00003 again after consolidating for over 48 hours. Analysts predict it may reach $0.0008, ...
True Crime Junkies Buy Sonar Boat to Solve Cold-Case Mysteriesby Lilu Anderson 06.04.2024True-crime enthusiasts take to cold cases, exploring disappearances. YouTube plays a key role as Florida's abundance of water piques interest. ...
German Stocks Close Mixed: DAX Up 0.15%, Siemens Energy AG Leads Gainersby Mark Eisenberg 06.04.2024Siemens Energy AG performed well, rising 3.03% at the close, while Deutsche Post AG NA O.N. fell 1.42%. Rheinmetall AG ...
Is AMD Stock the Next Nvidia? Top Investor Thinks Soby Mark Eisenberg 06.04.2024Investors are advised to keep an eye on the AI market, recognizing the potential of AMD stock as AI emerges ...
Top 56 Fully Remote Jobs in April 2024: Apple, Amazon, Airbnb & Moreby Lilu Anderson 06.04.2024Apple now requires most employees to work in the office three days a week, while Amazon, Airbnb, and Sony offer ...
Warren Buffett’s Top 8 AI Stocks: Is Apple the Leader?by Mark Eisenberg 06.04.2024Apple (AAPL) is the largest AI holding for Warren Buffett, while Microsoft (MSFT) has also thrived in the AI boom. ...
Bitgert Coin Price Projection: Surging to $0.00001!by John Darbie 06.04.2024Bitcoin, Ethereum, and Bitgert Coin may experience a surge as bullish momentum builds. Bitgert is expected to be lucrative by ...
Pfizer and Moderna Stocks: Down 30% and 27% – Buy and Holdby Terry Bingman 06.04.2024Pfizer and Moderna have struggled in the stock market, but Pfizer has a substantial pipeline of programs. Moderna's success is ...